AER  Vol.1 No.1 , March 2013
Dexamethasone treatment alters kinetics properties of liver mitochondrial F0.F1-ATPase and membrane lipid profiles in developing and adult rats
ABSTRACT
Dexamethasone—a potent synthetic glucocorticoid—has multiple diagnostic and therapeutic applications in wide range of age groups. However, the side-effects of dexamethasone (Dex) treatment including those on development are becoming increasingly apparent. Since the developmental processes are energy-dependent, we examined the effects of chronic Dex treatment on kinetics properties of liver mitochondrial F0.F1-ATPase and mitochondrial membrane lipid profiles in rats belonging to different developmental age groups (2, 3, 4 and 5 weeks) and in adults (~8 weeks). The animals were treated with a subcutaneous dose of 2 mg of Dex/kg body weight (or saline as vehicle) for three alternative days (at around 7.00 A.M.) prior to the day of sacrifice. Dex treatment resulted in significant reduction in F0.F1-ATPase activity in developmental age groups and in adults as compared to their age-matched vehicle-treated control group. The substrate kinetics analysis of F0.F1-ATPase resolved Km and Vmax values in 3 components in all the control age groups; whereas Dex treatment significantly altered the Km and Vmax values or abolished the entire components in age-specific manner. Dex treatment significantly lowered the energy of activation and altered phase transition temperature (TtoC) in all the developmental age groups and in adults. Dex treatment significantly increased the contents of total phospholipid (TPL), individual phospholipids classes and cholesterol (CHL) in all the developmental age groups whereas opposite pattern was observed in adults. The mitochondrial membrane became more fluidized in the developing age groups (2, 4 and 5 weeks); whereas no change was observed in 3-week and adult groups following Dex treatment. In present study, our data demonstrate comprehensive deleterious effects of chronic Dex treatment on liver mitochondrial membrane structure and F0.F1-ATPase functional properties with respect to energy metabolism. At the same time, our data also warns against excessive repeated use of antenatal DEX in treatments in growing and adult human patients.

Cite this paper
Pandya, J., Agarwal, N., Modi, H. and Katyare, S. (2013) Dexamethasone treatment alters kinetics properties of liver mitochondrial F0.F1-ATPase and membrane lipid profiles in developing and adult rats. Advances in Enzyme Research, 1, 1-15.
References
[1]   Schimmer, B.P. and Parker, K.L. (2001) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Gilman, A.G., Hardman, J.G. and Limbird, L.E., Eds., The Pharmacological Basis of Therapeutics, 10th Edition, The McGraw-Hill Companies, New York, 1635-1648.

[2]   Whitelaw, A. and Thoresen, M. (2000) Antenatal steroids and the developing brain. Archives of Disease in Childhood, Fetal and Neonatal Edition, 83, F154-F157. doi:10.1136/fn.83.2.F154

[3]   Gerrard, G.E. and Franks, K.N. (2004) Overview of the diagnosis and management of brain, spine, and meningeal metastases. Journal of Neurology, Neurosurgery and Psychiatry, 75, ii37-ii42. doi:10.1136/jnnp.2004.040493

[4]   Hagberg, H. and Jacobsson, B. (2005) Brain injury in preterm infants—What can the obstetrician do? Early Human Development, 81, 231-235. doi:10.1016/j.earlhumdev.2005.01.003

[5]   Kumar, P. (2005) Effect of decreased use of postnatal corticosteroids on morbidity in extremely low birthweight infants. American Journal of Perinatology, 22, 77-81. doi:10.1055/s-2005-837274

[6]   Rastogi, A., et al. (1996) A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics, 98, 204-210.

[7]   Romagnoli, C., et al. (1999) Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology, 59, 266-274. doi:10.1159/000028329

[8]   Tsuneishi, S., et al. (1991) Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain. Development Brain Research, 61, 117-123. doi:10.1016/0165-3806(91)90121-X

[9]   Brocklehurst, P., et al. (1999) Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK. An International Journal of Obstetrics and Gynaecology, 106, 977-979. doi:10.1111/j.1471-0528.1999.tb08440.x

[10]   Leung, T.N., et al. (2003) Repeated courses of antenatal corticosteroids: Is it justified? Acta Obstetricia et Gynecologica Scandinavica, 82, 589-596. doi:10.1034/j.1600-0412.2003.00204.x

[11]   Wapner, R. (2004) Antenatal corticosteroids: We continue to learn. American Journal of Obstetrics and Gynecology, 190, 875. doi:10.1016/j.ajog.2004.01.045

[12]   Flagel, S.B., et al. (2002) Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. American Journal of Physiology, Regul atory, Integrative and Comparative Physiology, 282, R55-R63.

[13]   Barrington, K.J. (2001) The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs. BMC Pediatrics, 1, 1. doi:10.1186/1471-2431-1-1

[14]   Doyle, L. and Davis, P. (2000) Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function. Journal of Paediatrics and Child Health, 36, 101-107. doi:10.1046/j.1440-1754.2000.00481.x

[15]   Neal Jr., C.R., et al. (2004) Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 287, R375-R385. doi:10.1152/ajpregu.00012.2004

[16]   Haouzi, D., et al. (2000) Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology, 32, 303-311. doi:10.1053/jhep.2000.9034

[17]   Jacobs, C.M., et al. (2006) Dexamethasone induces cell death which may be blocked by NMDA receptor antagonists but is insensitive to Mg2+ in cerebellar granule neurons. Brain Research, 1070, 116-123. doi:10.1016/j.brainres.2005.10.093

[18]   Pandya, J.D., Agarwal, N.A. and Katyare, S.S. (2007) Dexamethasone treatment differentially affects the oxidative energy metabolism of rat brain mitochondria in developing and adult animals. International Journal of Developmental Neuroscience, 25, 309-316. doi:10.1016/j.ijdevneu.2007.05.001

[19]   Pandya, J.D., Agarwal, N.A. and Katyare, S.S. (2004) Effect of dexamethasone treatment on oxidative energy metabolism in rat liver mitochondria during postnatal developmental periods. Drug and Chemical Toxicology, 27, 389-403. doi:10.1081/DCT-200039778

[20]   Ferguson, S.A. and Holson, R.R. (1999) Neonatal dexamethasone on day 7 causes mild hyperactivity and cerebellar stunting. Neurotoxicology and Teratology, 21, 71-76. doi:10.1016/S0892-0362(98)00029-4

[21]   Brown, R.E. and Cunningham, C.C. (1982) Negatively charged phospholipid requirement of the oligomycin- sensitive mitochondrial ATPase. Biochimica Biophysica Acta, 684, 141-145. doi:10.1016/0005-2736(82)90059-1

[22]   Hoch, F.L. (1992) Cardiolipins and biomembrane function. Biochimica Biophysica Acta, 1113, 71-133. doi:10.1016/0304-4157(92)90035-9

[23]   Ahlersova, E., Ahlers, I. and Smajda, B. (1992) Influence of light regimen and time of year on circadian oscillations of insulin and corticosterone in rats. Physiology Research, 41, 307-314.

[24]   Swegert, C.V., Dave, K.R. and Katyare, S.S. (1999) Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mechanisms of Ageing and Development, 112, 27-42. doi:10.1016/S0047-6374(99)00051-2

[25]   Katyare, S.S., et al. (2007) Thyroid hormone-induced alterations in membrane structure-function relationships: Studies on kinetic properties of rat kidney microsomal Na(+),K (+)-ATPase and lipid/phospholipid profiles. Journal of Membrane Biology, 219, 71-81. doi:10.1007/s00232-007-9063-7

[26]   Fiske, C.H. and Subbarow, Y. (1925) Colorimetric determination of phosphorus. Journal of Biological Chemistry, 66, 375-400.

[27]   Dixon, M. and Webb, E.C. (1979) Enzymes, Longman, London.

[28]   Patel, H.G., et al. (2000) Kinetic attributes of Na+, K+ ATPase and lipid/phospholipid profiles of rat and human erythrocyte membrane. Z Naturforsch C, 55, 770-777.

[29]   Raison, J.K. (1972) The influence of temperature-induced phase changes of the kinetics of respiration and other membrane-associated enzyme system. Bioenergetics, 4, 559-583.

[30]   Folch, J., Lees, M. and Sloane Stanley, G.H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry, 226, 497-509.

[31]   Zlatkis, A., Zak, B. and Boyle, A.J. (1953) A new method for the direct determination of serum cholesterol. Journal of Laboratory and Clinical Medicine, 41, 486-492.

[32]   Bartlett, G.R. (1959) Phosphorus assay in column chromatography. Journal of Biological Chemistry, 234, 466- 468.

[33]   Pandya, J.D., Dave, K.R. and Katyare, S.S. (2001) Effect of long-term aluminum feeding on lipid/phospholipid profiles of rat brain synaptic plasma membranes and microsomes. Journal of Alzheimers Disease, 3, 531-539.

[34]   Stahl, E. (1969) Apparatus and general techniques. In: Stahl, E., Ed., TLC in thin layer chromatography: A Laboratory Handbook, 2nd Edition, Springer-Verlag, New York.

[35]   Bangur, C.S., Howland, J.L. and Katyare, S.S. (1995) Thyroid hormone treatment alters phospholipid composition and membrane fluidity of rat brain mitochondria. Biochemical Journal, 305, 29-32.

[36]   Mehta, J.R., et al. (1991) Lipid fluidity and composition of the erythrocyte membrane from healthy dogs and Labrador retrievers with hereditary muscular dystrophy. Neurochemical Research, 16, 129-135. doi:10.1007/BF00965700

[37]   Van Blitterswijk, W.J., Van Hoeven, R.P. and Van der Meer, B.W. (1981) Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochimica Biophysica Acta, 644, 323-332. doi:10.1016/0005-2736(81)90390-4

[38]   Lowry, O.H., et al. (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.

[39]   Arvier, M., et al. (2007) Adenine nucleotide translocator promotes oxidative phosphorylation and mild uncoupling in mitochondria after dexamethasone treatment. American Journal of Physiology, Endocrinology and Metabolism, 293, E1320-E1324. doi:10.1152/ajpendo.00138.2007

[40]   Dumas, J.F., et al. (2003) Mitochondrial energy metabolism in a model of undernutrition induced by dexamethasone. British Journal of Nutrition, 90, 969-977. doi:10.1079/BJN2003980

[41]   Roussel, D., et al. (2003) Dexamethasone treatment specifically increases the basal proton conductance of rat liver mitochondria. FEBS Letters, 541, 75-79. doi:10.1016/S0014-5793(03)00307-7

[42]   Desquiret, V., et al. (2008) Mitochondrial effects of dexamethasone imply both membrane and cytosolicinitiated pathways in HepG2 cells. International Journal of Biochemistry and Cell Biology, 40, 1629-1641. doi:10.1016/j.biocel.2007.12.010

[43]   Tsiriyotis, C., Spandidos, D.A. and Sekeris, C.E. (1997) The mitochondrion as a primary site of action of glucocorticoids: Mitochondrial nucleotide sequences, showing similarity to hormone response elements, confer dexamethasone inducibility to chimaeric genes transfected in LATK-cells. Biochemical and Biophysical Research Communications, 235, 349-354. doi:10.1006/bbrc.1997.6787

[44]   Begum, N., Tepperman, H.M. and Tepperman, J. (1984) Effect of dexamethasone on adipose tissue and liver pyruvate dehydrogenase and its stimulation by insulingenerated chemical mediator. Endocrinology, 114, 99-107. doi:10.1210/endo-114-1-99

[45]   Demonacos, C., et al. (1995) The mitochondrion as a primary site of action of glucocorticoids: The interaction of the glucocorticoid receptor with mitochondrial DNA sequences showing partial similarity to the nuclear glucocorticoid responsive elements. The Journal of Steroid Biochemistry and Molecular Biology, 55, 43-55. doi:10.1016/0960-0760(95)00159-W

[46]   Rambal, A.A., et al. (2009) MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM. Leukemia, 23, 1744-1754. doi:10.1038/leu.2009.80

[47]   Sionov, R.V., et al. (2006) Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. Journal of Experimental Medicine, 203, 189-201. doi:10.1084/jem.20050433

[48]   Nuutinen, U., et al. (2006) Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line. Experimental Cell Research, 312, 322-30.

[49]   Marchetti, P., et al. (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. Journal of Experimental Medicine, 184, 1155-1160. doi:10.1084/jem.184.3.1155

[50]   Liu, Y., et al. (2007) Postnatal treatment with dexamethasone perturbs hepatic and cardiac energy metabolism and is associated with a sustained atherogenic plasma lipid profile in suckling rats. Pediatric Research, 61, 165-170. doi:10.1203/pdr.0b013e31802d89ff

[51]   Letteron, P., et al. (1997) Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation. American Journal of Physiology, 272, G1141-G1150.

[52]   Amin, S.B., et al. (1999) Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia. Archives Pediatric in Adolescent Medicine, 153, 795-800.

[53]   Cabello, M.A., et al. (1990) Effect of adrenalectomy and glucocorticoid treatment on the levels of an insulinsensitive glycosyl-phosphatidylinositol in isolated rat hepatocytes. Molecular and Cell Endocrinology, 68, R1-R5. doi:10.1016/0303-7207(90)90173-6

[54]   Allan, E.H. and Titheradge, M.A. (1984) Effect of treatment of rats with dexamethasone in vivo on gluconeogenesis and metabolite compartmentation in subsequently isolated hepatocytes. Biochemical Journal, 219, 117-123.

[55]   Foster, P.C. and Bailey, E. (1976) Changes in the activities of the enzymes of hepatic fatty acid oxidation during development of the rat. Biochemical Journal, 154, 49-56.

[56]   Carroll, J.E., et al. (1989) Acyl-CoA dehydrogenase enzymes during early postnatal development in the rat. Biology of Neonate, 55, 185-190. doi:10.1159/000242915

[57]   Nagao, M., Parimoo, B. and Tanaka, K. (1993) Developmental, nutritional, and hormonal regulation of tissue- specific expression of the genes encoding various acyl- CoA dehydrogenases and alpha-subunit of electron transfer flavoprotein in rat. Journal of Biological Chemistry, 268, 24114-24124.

[58]   Kapitulnik, J., Weil, E. and Rabinowitz, R. (1986) Glucocorticoids increase the fluidity of the fetal-rat liver microsomal membrane in the perinatal period. Biochemical Journal, 239, 41-45.

[59]   Kaur, N., Sharma, N. and Gupta, A.K. (1989) Effects of dexamethasone on lipid metabolism in rat organs. Indian Journal of Biochemistry and Biophysics, 26, 371-376.

[60]   Mangiapane, E.H. and Brindley, D.N. (1986) Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochemical Journal, 233, 151-160.

[61]   Brenner, R.R., Ayala, S. and Garda, H.A. (2001) Effect of dexamethasone on the fatty acid composition of total liver microsomal lipids and phosphatidylcholine molecular species. Lipids, 36, 1337-1345. doi:10.1007/s11745-001-0850-1

[62]   Holloway, C.T. and Margolis, R.N. (1980) Dynamic lipid changes in rapidly proliferating hepatic smooth endoplasmic reticulum during acute dexamethasone treatment of adrenalectomized rats. Lipids, 15, 1037-1043. doi:10.1007/BF02534320

[63]   Di Paola, M. and Lorusso, M. (2006) Interaction of free fatty acids with mitochondria: Coupling, uncoupling and permeability transition. Biochimica et Biophysica Acta, 1757, 1330-1337. doi:10.1016/j.bbabio.2006.03.024

[64]   Wojtczak, L. and Wieckowski, M.R. (1999) The mechanisms of fatty acid-induced proton permeability of the inner mitochondrial membrane. Journal of Bioenergetics and Biomembranes, 31, 447-455. doi:10.1023/A:1005444322823

[65]   Lardy, H. and Copenhaver, Jr., J.H. (1954) Efficiency of oxidative phosphorylation. Nature, 174, 231-232. doi:10.1038/174231b0

[66]   Loomis, W.F. and Lipmann, F. (1949) Inhibition of phosphorylation by azide in kidney homogenate. Journal of Biological Chemistry, 179, 503.

[67]   Davis, L.M., Rho, J.M. and Sullivan, P.G. (2008) UCP- mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: Correlations to dietary modulations. Epilepsia, 49, 117-119. doi:10.1111/j.1528-1167.2008.01854.x

[68]   Sluse, F.E., et al. (2006) Mitochondrial UCPs: New insights into regulation and impact. Biochimica et Biophysica Acta, 1757, 480-485. doi:10.1016/j.bbabio.2006.02.004

[69]   Agius, L., Chowdhury, M.H. and Alberti, K.G. (1986) Regulation of ketogenesis, gluconeogenesis and the mitochondrial redox state by dexamethasone in hepatocyte monolayer cultures. Biochemical Journal, 239, 593-601.

[70]   Serra, D., et al. (1993) Regulation of mitochondrial 3- hydroxy-3-methylglutaryl-coenzyme a synthase protein by starvation, fat feeding, and diabetes. Archives of Biochemistry and Biophysics, 307, 40-45. doi:10.1006/abbi.1993.1557

[71]   Fine, E.J., et al. (2009) Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell International, 9, 14. doi:10.1186/1475-2867-9-14

 
 
Top